In aggregate, these results implicate a completely distinct mechanism of action for SPINK1 in protection of ovarian cancer cells from anoikis; our data demonstrate that anoikis protection is conferred via inhibition of trypsin or a trypsin-like serine protease, and does not require modulation of EGFR signaling. The gene discussed is SPINK1; the disease is ovarian carcinoma.